Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Common Equity (2024 - 2025)

Historic Common Equity for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $164.1 million.

  • Kestra Medical Technologies' Common Equity rose 16936.57% to $164.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $164.1 million, marking a year-over-year increase of 16936.57%. This contributed to the annual value of $205.4 million for FY2025, which is 19810.34% up from last year.
  • Per Kestra Medical Technologies' latest filing, its Common Equity stood at $164.1 million for Q4 2025, which was up 16936.57% from $184.2 million recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year Common Equity high stood at $205.4 million for Q2 2025, and its period low was -$468.2 million during Q1 2025.